Skip to main content

Day: June 24, 2025

Aardvark Therapeutics to Join Prader-Willi Syndrome Community at the 2025 United in Hope Conference

SAN DIEGO, June 24, 2025 (GLOBE NEWSWIRE) — Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, today announced that members of its team will join the Prader-Willi syndrome (PWS) community at the 2025 United in Hope Conference, taking place June 24 to 28 in Phoenix, Arizona. “It’s an honor to stand alongside the families, advocates, scientists and clinicians who are working to transform the lives of those affected by PWS,” said Dr. Tien Lee, Chief Executive Officer of Aardvark Therapeutics. “The United in Hope Conference is a powerful reflection of the passion, resilience and shared purpose that drive our mission. We’re proud to contribute to the...

Continue reading

BriaCell Announces Positive Recommendation from Data Safety Monitoring Board for Pivotal Phase 3 Study in Metastatic Breast Cancer

Independent DSMB identifies no safety concerns, and recommends continuation of BriaCell’s pivotal Phase 3 study of Bria-IMT™ plus immune check point inhibitor Review marks third consecutive positive recommendation by DSMB Study is being conducted under FDA Fast Track DesignationPHILADELPHIA and VANCOUVER, British Columbia, June 24, 2025 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, is pleased to report that the independent Data Safety Monitoring Board (DSMB) has completed its third scheduled safety data review of BriaCell’s pivotal Phase 3 study of Bria-IMT plus immune checkpoint inhibitor (CPI) in metastatic breast cancer (NCT06072612). Following its...

Continue reading

Endeavour Silver Amends and Restates Project Loan Credit Facility to Include Additional Credit Facility of US$15 Million

VANCOUVER, British Columbia, June 24, 2025 (GLOBE NEWSWIRE) —  Endeavour Silver Corp. (“Endeavour” or the “Company”) (NYSE: EXK; TSX: EDR) is pleased to announce that its wholly-owned subsidiary, Terronera Precious Metals, S.A. de C.V. (Terronera) has amended and restated the previously announced senior secured debt facility (the “Credit Facility”) with ING Capital LLC (together with ING Bank N.V.) and Societe Generale acting as Joint Lead Arrangers. The Credit Facility was announced by press release on October 10, 2023. Among other things, the Credit Facility was amended and restated to increase the principal amount of up to $120,000,000 by an additional $15,000,000, bringing the aggregate principal amount up to $135,000,000. Proceeds from the Credit Facility will be used towards completing commissioning at the Company’s Terronera...

Continue reading

ZenaTech Expands Drone as a Service (DaaS) for Government and Defense, Signing an Offer to Acquire a Virginia-Headquartered Tri-State Land Survey and Engineering Firm Serving Major US Federal Clients

VANCOUVER, British Columbia, June 24, 2025 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology company specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), enterprise SaaS, and Quantum Computing solutions, announces it has signed an offer to acquire a Virginia-headquartered land survey and civil engineering firm with operations in three states and expertise serving major US federal government agencies and regional infrastructure programs. Upon completion, this acquisition would mark ZenaTech’s first entry into the states of Virginia, North Carolina, and South Carolina, accelerating the Company’s expansion across the Southeast region of the US. “This acquisition reinforces our DaaS business model expansion objectives to provide drone innovation supporting...

Continue reading

Advanced Flower Capital Schedules Earnings Release and Conference Call for the Second Quarter Ending June 30, 2025

WEST PALM BEACH, Fla., June 24, 2025 (GLOBE NEWSWIRE) — Advanced Flower Capital Inc. (Nasdaq: AFCG) (“AFC”) today announced that it will release its financial results for the second quarter ending June 30, 2025 on Thursday, August 14th, 2025 before market open. Management will review AFC’s financial results at 10:00 am ET via webcast available on the Investor Relations section of AFC’s website found here AFC — Investor Relations. Participants are also invited to access the conference call by registering in advance at this link. A replay will be available one hour after the event. AFC distributes its earnings releases via its website and email lists. Those interested in receiving firm updates by email can sign up for them here. About Advanced Flower Capital Inc. Advanced Flower Capital Inc. (Nasdaq: AFCG) is a leading commercial...

Continue reading

Sunrise Realty Trust Schedules Earnings Release and Conference Call for the Second Quarter Ending June 30, 2025

WEST PALM BEACH, Fla., June 24, 2025 (GLOBE NEWSWIRE) — Sunrise Realty Trust, Inc. (“SUNS”) (Nasdaq: SUNS), a lender on the Tannenbaum Capital Group (“TCG”) Real Estate platform, today announced that it will release its financial results for the second quarter ending June 30, 2025 on Thursday, August 7th, 2025 before market open. Management will review SUNS’ financial results at 10:00 am ET via webcast available on the Investor Relations website at ir.sunriserealtytrust.com. Participants are also invited to access the conference call by registering in advance at this link. A replay will be available one hour after the event. SUNS distributes its earnings releases via its website and email lists. Those interested in receiving firm updates by email can sign up for them here. About Sunrise Realty Trust, Inc. Sunrise Realty Trust,...

Continue reading

Parsons Corporation is Ready Now to Build America’s Brand New, State Of-The-Art Air Traffic Control System

Parsons and IBM join forces to design solutions for a national airspace system with enhanced safety and efficiency CHANTILLY, Va., June 24, 2025 (GLOBE NEWSWIRE) — Today, Parsons Corporation (NYSE: PSN) and IBM (NYSE: IBM) announced a collaboration to deliver on President Donald Trump’s and Transportation Secretary Sean Duffy’s vision for a brand new, state of-the-art air traffic control system. This collaboration directly responds to Secretary Duffy’s call for world-class innovators to rapidly spearhead the overhaul of the Federal Aviation Administration’s (FAA) National Airspace System (NAS), prioritizing an open vendor agnostic approach that enables the agency to leverage the latest technologies and continuously improve their systems based on real-time feedback and evolving needs. Parsons would serve as the prime contractor...

Continue reading

Constellium Honored with Three Supplier Awards from Airbus

PARIS, June 24, 2025 (GLOBE NEWSWIRE) — Constellium SE (NYSE: CSTM) is proud to announce that it has been recognized with three awards at the 2025 edition of Airbus’ Supply Chain & Quality Improvement Program (SQIP), held in early June. The program honors suppliers that consistently deliver excellence in their quality & delivery performance and industrial maturity. Constellium’s facilities in Issoire and Montreuil-Juigné were honored for their significant contributions to Airbus’ supply chain: Issoire – Accredited Supplier AwardFor the second consecutive year, the Issoire plant received the “Accredited Supplier” award – the highest Airbus SQIP program distinction. This recognition highlights the facility’s sustained excellence and reliability over time with regards to performance. Issoire – Sustainability Special Recognition     ...

Continue reading

Abeona Therapeutics® Announces Publication in The Lancet of Phase 3 VIITAL™ Study Data in Recessive Dystrophic Epidermolysis Bullosa

– RDEB is a lifelong debilitating, blistering skin disease associated with large and painful wounds that often remain open for years and cause significant clinical burden, including pain, itch, and risk of squamous cell carcinoma – – ZEVASKYN™ (prademagene zamikeracel) demonstrated significant wound healing and pain reduction after a single treatment with a favorable safety profile in large chronic RDEB wounds – – ZEVASKYN is the first and only autologous cell-based gene therapy FDA-approved to treat RDEB wounds in adult and pediatric patients – CLEVELAND, June 24, 2025 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that The Lancet has published results from the pivotal Phase 3 VIITAL study (NCT04227106) evaluating the efficacy and safety of ZEVASKYN (prademagene...

Continue reading

OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors

WALTHAM, Mass., June 24, 2025 (GLOBE NEWSWIRE) — OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced the appointment of Steve Silvestro, currently serving as the Company’s Chief Executive Officer, to its Board of Directors, effective as of June 20, 2025. Mr. Silvestro joined the Company in 2019 and has been the Company’s CEO since March 2025, after serving as the interim CEO from January 2025. The appointment of Mr. Silvestro, with his knowledge of the Company and expertise in the industry, will enhance overall leadership and greatly contribute to the Company’s ability to execute its value creation plans and support key initiatives to deliver on its customer and shareholder...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.